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Abstract
Background Reporting financial disclosures has become
standard practice in both journal publications and during
oral forum at scientific meetings. Despite this, the effect of
reporting a financial disclosure of any member of an au-
thorgroup, on the tone of the conclusion of an article has
gained little attention. This study was performed to deter-
mine what effect reporting a financial disclosure has on the
conclusion of an article.
Methods A literature search for all articles on interspi-
nous devices and cervical disc prostheses, published from
January 1st, 2008 until December 1st, 2010 was performed.
Financial disclosures were reported, as were funding by
commercially active parties. The tone of the conclusions
was graded as positive, neutral or negative.
Results The odds ratio (OR) for a positive conclusion in
cases where a financial disclosure was reported was 16.5
(95% CI: 4.7–58.1). Effect modification occurs with the
presence of funding by a commercially active party. In
cases where a financial disclosure was reported and funding
was available for the study, the OR was 1.0 (95% CI:
0.08–12.6), whilst the OR was 33.3 (95%CI: 4.2–262.3) if
funding was not provided. This discrepancy is mainly due to
the large number of articles with a neutral/negative con-
clusion if the authors failed to report any financial disclo-
sure and were not funded by a commercially active party.
Conclusions Reporting a financial disclosure is a potential
source of bias. Authors with disclosed financial relation-
ships less often publish articles with a neutral/negative
conclusion. This source of bias should certainly be taken
into account during the critical appraisal of articles, par-
ticularly when the quality of the literature is being assessed.
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Introduction
Evidence based medicine is generally accepted. Unbiased,
high quality research is needed to answer questions regard-
ing clinical effectiveness, cost -utility or cost -effectiveness
of new treatments. Collaboration with the industry is
essential to initiate time and financially consuming trials.
Major sources of biases have been well established, and most
of which have been quantitatively been investigated. Others
have been recognized and discussed, yet research on them
has rarely been performed. The former has been the case for
the bias due to financial dependence of the investigator on a
company that has developed or sold the product, under
investigation [1–4]. We hypothesize that a financial disclo-
sure was related to the conclusion of a study investigating the
product for which the disclosure was made. Therefore, this
study was performed to investigate whether financial dis-
closure is related to reporting a favorable result of the product
under investigation.
Methods
Because of the background of the first author is mainly in
spinal surgery, a literature search in Pubmed was
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performed on spinal implants. The implants chosen were
interspinous distraction devices (ISD) and cervical disc
prostheses. The search was restricted from January, 1st
2008 until December 1st, 2010. The search string for ISD
was ((interspinous) AND (device OR implant OR spacer))
AND lumbar. The search string for cervical arthroplasty
(CAP) included cervical AND (disc OR disk) AND
(prosthesis OR prostheses OR arthroplasty).
For both searches, the language was restricted to Eng-
lish, German, French or Dutch. The titles and abstracts
were studied. All articles were included except, letters to
the editor, editorials and articles not pertaining to ISD or
cervical arthroplasty. The remaining articles were com-
pletely studied to search for disclosures or funding by
commercially active parties related to the Product or
Technique under Investigation (PTI).
Since the conclusion is, for most readers, an invitation to
read the whole article and many times also the main mes-
sage readers remember, the abstract was the primary subject
of study. The conclusions within the abstracts were exam-
ined for remarks on the PTI. The conclusion was then
qualified as positive, neutral or negative. A conclusion was
graded positive if a statement was included that the PTI
exhibited a better or even slightly better performance. It was
also deemed positive if the study did not show any superi-
ority but an assumption was made that the use of the PTI
would contribute to a better clinical or biomechanical out-
come. These statements were characterized by adjectives
including promising, encouraging, favorable, and the like.
A conclusion was qualified as neutral, if the results of the
study did not demonstrate any difference and without any
assumptions being made about the possibility of a better
outcome. A negative conclusion included a clear statement
that the PTI did not carry any benefit above another product
or technique, performed more poorly or emphasized mainly
complications or adverse events of the POT.
The qualification of the conclusion was subsequently
correlated with the presence of any financial disclosures of
the authors. If a member of the author group had a dis-
closure in another article and the article of interest did not
explicitly mention disclosures, the article was then inclu-
ded in a separate group as having a financial relationship,
without explicit disclosure. For the purpose of analysis, this
group was combined with the group that clearly stated
disclosures. Moreover, whether the funding to support the
work by a commercial party related directly or indirectly to
the PTI was noted. The type of financial disclosure or
funding was not separately investigated.
Two of the authors (RB, HD) independently investigated
the retrieved articles. In cases of discrepancy between the
two authors, they deliberated about the findings. If an
agreement could not be reached, the opinion of a third
investigator (JB) was obtained. The inter- observer agree-
ment for qualifying the conclusion and the relation to
funding or disclosures was determined as kappa (j).
Statistical analysis was performed using a commercially
available program (SPSS 17.0). Logistic regression was
used to calculate odds ratios (OR). 95% confidence inter-
vals (95%CI) were defined. Statistical significance was
assumed when the p value was \0.05.
Results
The search on ISD resulted in the titles and abstracts of
66 articles. Fourteen articles were excluded because they
did not relate to the subject of investigation, or did not
present the results of a study. Editorials and letters to
editors were likewise excluded, as were studies with
inadequate abstracts. Therefore, 51 complete articles on
ISD were included in this study. 215 articles were
retrieved after a search was performed for CAP. 109
complete articles that dealt with the subject of interest
were included. In total, 160 articles were studied. The
results are depicted in Appendix. A summary of the
results is shown in Table 1.
Table 1 Number of articles on interspinous devices and cervical arthroplasty from January 1st, 2008 till December 1st, 2010 related to financial
disclosure, funding and the conclusion
Financial disclosure
reported
No financial disclosure
reported
No need to report
disclosures
Disclosures known but no
need to mention them
Total
Funding No funding Funding No funding Funding No funding Funding No funding
Positive conclusion 17 24 10 24 – 20 1 8 104
Neutral/negative conclusion 2 1 1 32 – 20 – – 56
Total 19 25 11 56 – 40 1 8 160
Total 44 67 40 9 160
Financial disclosure reported: clear statement of having a financial disclosure is made in the publication, No financial disclosure reported: a clear
statement of not having a financial disclosure is made in the publication; No need to report disclosures: the journal did not ask to publish
disclosures relating to the article and they are not clearly stated; Disclosures known but no need to mention them: form other publications it was
known that a financial disclosure was present but the journal in which the article of interest was published did not publish any financial
relationships
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In 21 articles from the first set of articles, the pre-
liminary qualification of the tone of these articles differed
between the two investigators. After discussion and delib-
eration, the qualification was adapted without the need for
asking the opinion of the third researcher. Kappa was 0.87.
In 40 articles, no financial disclosure was reported.
Therefore, based on 120 articles, it could be estimated that
the OR of reporting a positive conclusion while having a
financial disclosure was 16.5 (95% CI: 4.7–58.1). If for the
author groups of all 40 articles for which the disclosure was
not stated explicitly, a financial disclosure was assumed
(worst case scenario), the OR of reporting a positive con-
clusion while having a financial relationship was 3.0 (95%
CI: 1.5–5.8), and if it was assumed that they indeed did
have not have a financial relationship (best case scenario)
the OR was 16.4 (95% CI: 4.8–55.7). The OR for a positive
conclusion with a stated financial disclosure was 16.0 (95%
CI: 1.8–142.4), and 16.7 (95% CI: 3.6–78.1), for studies on
ISD and CAP, respectively.
The effect of funding of a study was also investigated.
The OR for a positive conclusion with both a stated
financial disclosure and funding by a commercially active
party was 1.0 (95% CI: 0.08–12.6), whilst the OR was 33.3
(95%CI: 4.2–262.3) if funding was not provided. There-
fore, the presence of funding contributed to effect modifi-
cation. The addition of an interaction term was statistically
significant (p = 0.035). The number of articles with a
negative conclusion, where both funding was not present
and a financial disclosure was not reported was quite
remarkable. The OR for reporting an article with a neutral/
negative conclusion in cases in which both financial dis-
closure and funding existed was 0.03 (95% CI: 0.0–0.2).
Discussion
The effect of financial relationships on the results of trials
has been subject of many articles. It has been demonstrated
that published funded trials report positive findings more
frequently [5]. This effect has been established as ‘‘fund-
ing-driven bias’’ [6]. This bias has been classically
restricted to articles reporting research related to pharma-
ceutical therapies.
Financial disclosures or conflict of interest of an author
or members of an author groups have also been extensively
discussed in the literature. In most instances, the articles
dealt with legal or ethical aspects of financial relationships.
The epidemiology of financial disclosures has likewise
been described [7]. However, the effect of financial dis-
closures on study outcomes has gained little attention.
This study clearly established the quantitative relation-
ship between financial disclosure and study outcome. The
method employed for qualifying the conclusions has not
been previously described. However, it is simple and
affords high inter-observer agreement, with a kappa of 0.86
being achieved. Although the implants under investigation
were only for use in spinal surgery, the conclusions here
should not be restricted to this specialty. The ORs for
studies on two different implants were essentially the same
(i.e. OR 16.0 and 16.7).
To our knowledge, this is the first reported analysis of
the effect modification having a financial disclosure has on
the nature of study conclusions, in the presence of funding.
The demonstrated difference is mainly due to the signifi-
cantly higher number of studies with a neutral/negative
conclusion, in the absence of funding and stated financial
disclosure. While this has been described previously, the
prior focus has been on the relationship between positive
findings and financial disclosure [8]. Considering the nat-
ure of commercially active parties, reporting articles with
negative conclusions regarding their products, is not in
their best interest. Their primary objective lies in promot-
ing their products. Therefore, it can be assumed that it is
more likely that they preferentially and actively support
any investigation which will result in a positive conclusion.
Publication bias could also contribute to the difference
in articles with positive and neutral/negative conclusions.
However, a clear distinction exists between the number of
articles with a negative conclusion that are funded, and
those that are not.
Therefore, the effect financial disclosure has on the
outcome of an article certainly exists and should be taken
into in account when interpreting the results and conclu-
sions of a study. Financial disclosure bias, as well as,
funding-driven bias should be considered when assessing
the quality of publications, particularly when performing a
meta-analysis. Furthermore, it should be added to the long
list of possible biases.
Studying the effect of a financial disclosure in articles
relating to interspinous devices, cervical disc prostheses, or
any other specific implant, medical device, or drug, within
a certain time period has a major advantage: the product of
interest is clearly defined and the interest of industry within
this time period is apparent. If this study would have
included any article within a certain time period, certainly a
dilution of the results would have occurred and more bias
would have been incorporated. For example, studies on
subjects that lack a commercial market, will be less fre-
quently funded and the authors will less often report a
financial disclosure. Therefore, it is assumed that the
results of this study can be extrapolated to other research
related to commercially available medical products. This is
substantiated by the nearly equal OR for the two different
spinal implants that are otherwise unrelated. Conversely,
including all articles on several subjects could contribute to
generalization of the findings of this study.
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A flaw of this study is that the financial disclosure itself is
not specified. Intuitively, stockholders may be more prone
to report positive results compared with those authors who
received minimal financial support. On the other hand, it is
common knowledge that even small gifts will positively
influence the opinion of a person towards the gift-related
product [9]. Furthermore, it has been established that the
description of financial disclosures widely differs and has
even been called vague [10, 11]. In 40 articles, the disclo-
sure was not stated. As was demonstrated in calculating the
best and worst case scenario, knowledge of the presence of
any financial disclosure would not affect the conclusion of
this study. Only the magnitude of the results would have
differed, although the OR of the forecasted best scenario
was probably underestimated. Based on the results of this
study, we believe that author groups with a financial dis-
closure report fewer articles with a neutral/negative con-
clusion. In our calculation, they were equally divided
between the groups with and without known financial dis-
closure. If this would be corrected, the OR increased dra-
matically in a best case scenario where none of the authors
had a financial disclosure.
Another criticism lies in the lack of qualification of the
methodology used in the evaluation of articles. Whether
the conclusion was correct based on the validity of the
results of each article, has not been verified in this study;
we examined only the summarized conclusion of the
results and their interpretation as given in the abstract of
each article. Therefore, the effect of a financial disclosure
on the tone of the conclusion, alone was evaluated.
An ambivalent attitude towards financial relationships
and research is currently warranted. Given that the devel-
opment of new drugs or implants is, in most instances,
dependent upon the financial support of the industry,
funding of research should be encouraged. On the other
hand and for purposes of independent critical appraisal of
the results, any financial relationships between industry and
researchers should be avoided and rejected. The attempts to
influence scientific publications by industry should be
minimized. An example is the nation-wide independent
research programme on drugs launched by the Italian
Medicines Agency (AIFA) in 2005. The challenges, fea-
sibility and future perspectives are well described [12].
Conclusion
Financial disclosures are an underestimated source of bias.
In fact, authors having a financial disclosure tend to less
often report a study with a neutral or negative conclusion.
This should be taken into careful consideration when
assessing the quality of a study.
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Appendix
See Table 2
Table 2 Tables with number of articles for interspinous devices and cervical arthroplasty separately from January 1st, 2008 till December 1st,
2010 related to financial disclosure, funding and the conclusion. References are included
Financial disclosure
reported
No financial disclosure
reported
Disclosures not
explicitly stated
Disclosures known but no
need to mention them
Total
Funding No funding Funding No funding Funding No funding Funding No funding
Interspinous devices
Positive conclusion 7[1–7] 6[8–13] 3[14, 15] 8[16–24] – 5[25–29] 1[30] 2[31, 32] 32
Neutral/negative conclusion 1[33] – 1[34] 10[35–44] – 7[45–51] 19
Total 8 6 4 18 0 12 1 2
Total 14 22 12 3 51
Cervical anthroplasty
Positive conclusion 10[52–61] 18[62–79] 7[80–86] 16[87–102] – 15[103–117] – 6[118–123] 71
Neutral/negative conclusion 1[124] 1[125] – 22[126–147] – 13[148–160] – – 36
Total 11 19 7 38 – 28 – 6 109
Total 30 45 28 6 109
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